Literature DB >> 7150899

Treatment of early localized breast cancer in elderly patients by Tamoxifen.

A Helleberg, B Lundgren, T Norin, S Sander.   

Abstract

Twenty-seven early localized breast cancer cases in elderly patients, 21 stage I and six stage II, were treated with Tamoxifen only. In 15 cases there was complete radiological remission and in seven cases partial remission or growth arrest. Five cases did not respond to treatment. Tamoxifen seemed to be a useful alternative treatment for this group of patients. Possibly tumour mass and growth rate may affect the response to antioestrogen treatment.

Entities:  

Mesh：

Substances：

Year:  1982        PMID： 7150899     DOI： 10.1259/0007-1285-55-655-511

Source DB:  PubMed          Journal:  Br J Radiol        ISSN： 0007-1285            Impact factor:   3.039


  5 in total

1.  Is surgical management compromised in elderly patients with breast cancer?

Authors:  H J Wanebo; B Cole; M Chung; M Vezeridis; B Schepps; J Fulton; K Bland
Journal:  Ann Surg       Date:  1997-05       Impact factor: 12.969

Review 2.  Breast cancer in the elderly.

Authors:  M Bellet; C Alonso; B Ojeda
Journal:  Postgrad Med J       Date:  1995-11       Impact factor: 2.401

3.  The tumour response of postmenopausal hormone receptor-positive breast cancers undergoing different types of neoadjuvant therapy: a meta-analysis.

Authors:  Yaling Wang; Lin He; Yuhua Song; Qian Wu; Haiji Wang; Biyuan Zhang; Xuezhen Ma
Journal:  BMC Womens Health       Date:  2020-01-31       Impact factor: 2.809

4.  Epidermal growth factor receptor (EGFr) status associated with failure of primary endocrine therapy in elderly postmenopausal patients with breast cancer.

Authors:  S Nicholson; P Halcrow; J R Sainsbury; B Angus; P Chambers; J R Farndon; A L Harris
Journal:  Br J Cancer       Date:  1988-12       Impact factor: 7.640

5.  Long-term follow-up of elderly patients with operable breast cancer treated with surgery without axillary dissection plus adjuvant tamoxifen.

Authors:  G Martelli; G DePalo; N Rossi; D Coradini; P Boracchi; E Galante; G Vetrella
Journal:  Br J Cancer       Date:  1995-11       Impact factor: 7.640
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.